Related Experiment Video
Updated: Dec 23, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Structural Heart Disease Emergencies
Jacob C Jentzer1,2, Bradley Ternus3, Mackram Eleid1
1Department of Cardiovascular Medicine, 4352Mayo Clinic Rochester, MN, USA.
Insights
Structural heart disease (SHD) emergencies require prompt diagnosis and tailored medical stabilization. Treatment strategies differ significantly between stenotic and regurgitant lesions to manage heart failure and cardiogenic shock.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Structural heart disease (SHD) emergencies encompass acute deterioration or new critical lesions.
- These emergencies can lead to heart failure and cardiogenic shock, often unresponsive to standard medical therapy.
- Prompt intervention, either surgical or percutaneous, is frequently necessary.
Purpose of the Study:
- To review initial medical stabilization strategies for SHD emergencies.
- To outline definitive therapeutic approaches for SHD emergencies.
- To differentiate management based on lesion type (stenotic vs. regurgitant).
Main Methods:
- Comprehensive Doppler echocardiography is the primary diagnostic tool.
- Medical stabilization protocols vary based on lesion type.
- Definitive therapies include surgical and percutaneous interventions.
Main Results:
- Doppler echocardiography identifies the cause and severity of SHD lesions.
- Management differs: regurgitant lesions need afterload reduction/inotropic support; stenotic lesions may need beta-blockade/vasoconstrictors.
- Emergent surgery has high mortality but is vital for ineligible patients.
Conclusions:
- Effective medical stabilization is crucial for managing SHD emergencies.
- Tailored interventions based on lesion type improve patient outcomes.
- Early diagnosis and appropriate therapy are key to reducing mortality in SHD emergencies.
Abstract:
Structural heart disease (SHD) emergencies include acute deterioration of a stable lesion or development of a new critical lesion. Structural heart disease emergencies can produce heart failure and cardiogenic shock despite preserved systolic function that may not respond to standard medical therapy and typically necessitate surgical or percutaneous intervention. Comprehensive Doppler echocardiography is the initial diagnostic modality of choice to determine the cause and severity of the underlying SHD lesion. Patients with chronic SHD lesions which deteriorate due to intercurrent illness (eg, infection or arrhythmia) may not require urgent intervention, whereas patients with an acute SHD lesion often require definitive therapy. Medical stabilization prior to definitive intervention differs substantially between stenotic lesions (aortic stenosis, mitral stenosis, left ventricular outflow tract obstruction) and regurgitant lesions (aortic regurgitation, mitral regurgitation, ventricular septal defect). Patients with regurgitant lesions typically require aggressive afterload reduction and inotropic support, whereas patients with stenotic lesions may paradoxically require β-blockade and vasoconstrictors. Emergent cardiac surgery for patients with decompensated heart failure or cardiogenic shock carries a substantial mortality risk but may be necessary for patients who are not eligible for catheter-based percutaneous SHD intervention. This review explores initial medical stabilization and subsequent definitive therapy for patients with SHD emergencies.
More Related Videos
Related Concept Videos
Introduction Cardiac Emergencies
Acute Coronary Syndrome I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy

